The Fédération Equestre Internationale (FEI) will host a two-day global congress to debate the use of non-steroidal anti-inflammatory drugs (NSAIDs) in competition. The FEI Congress on NSAIDs Usage and Medication in the Equine Athlete, which will be held in Lausanne, Switzerland, on Aug. 16-17, will include the presentation of educational and scientific papers as well as open debate.

The vote on the use of NSAIDs in competition will not be taken until the FEI General Assembly in Chinese Taipei, Nov. 1-6, but all interested parties are advised to register for the Congress early to book their places and ensure that their voices are heard in this debate.

The congress is open to national federations and representatives of all stakeholder groups, including veterinarians, officials, riders clubs, organizers, FEI laboratories, racing and breeding authorities, sponsors, the International Olympic Committee (IOC), and the media.